EE05090B1 - Tsklipostiinihend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,hendi ja preparaadi valmistamine ning selleks vajalik mikroorganism - Google Patents
Tsklipostiinihend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,hendi ja preparaadi valmistamine ning selleks vajalik mikroorganismInfo
- Publication number
- EE05090B1 EE05090B1 EEP200200599A EEP200200599A EE05090B1 EE 05090 B1 EE05090 B1 EE 05090B1 EE P200200599 A EEP200200599 A EE P200200599A EE P200200599 A EEP200200599 A EE P200200599A EE 05090 B1 EE05090 B1 EE 05090B1
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- compound
- tsipostin
- organism
- micro
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 229940127003 anti-diabetic drug Drugs 0.000 title 1
- 239000003472 antidiabetic agent Substances 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- 229930183107 cyclipostin Natural products 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 102000004882 Lipase Human genes 0.000 abstract 1
- 108090001060 Lipase Proteins 0.000 abstract 1
- 239000004367 Lipase Substances 0.000 abstract 1
- 241000187747 Streptomyces Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 235000019421 lipase Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10021731A DE10021731B4 (de) | 2000-05-04 | 2000-05-04 | Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben |
| PCT/EP2001/004652 WO2001083497A1 (de) | 2000-05-04 | 2001-04-25 | Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200200599A EE200200599A (et) | 2004-04-15 |
| EE05090B1 true EE05090B1 (et) | 2008-10-15 |
Family
ID=7640768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200599A EE05090B1 (et) | 2000-05-04 | 2001-04-25 | Tsklipostiinihend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,hendi ja preparaadi valmistamine ning selleks vajalik mikroorganism |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP1280812B1 (et) |
| JP (1) | JP5038572B2 (et) |
| KR (1) | KR100779867B1 (et) |
| CN (1) | CN1216890C (et) |
| AR (1) | AR028398A1 (et) |
| AT (1) | ATE288442T1 (et) |
| AU (2) | AU2001262229B2 (et) |
| BR (1) | BR0110459A (et) |
| CA (1) | CA2407808C (et) |
| CZ (1) | CZ20023547A3 (et) |
| DE (2) | DE10021731B4 (et) |
| DK (1) | DK1280812T3 (et) |
| EE (1) | EE05090B1 (et) |
| ES (1) | ES2236234T3 (et) |
| HK (1) | HK1055745A1 (et) |
| HR (1) | HRP20020864A2 (et) |
| HU (1) | HUP0300306A3 (et) |
| IL (2) | IL152612A0 (et) |
| MX (1) | MXPA02010297A (et) |
| NO (1) | NO330438B1 (et) |
| NZ (1) | NZ522352A (et) |
| PL (1) | PL358328A1 (et) |
| PT (1) | PT1280812E (et) |
| RU (1) | RU2266911C2 (et) |
| SK (1) | SK15602002A3 (et) |
| WO (1) | WO2001083497A1 (et) |
| YU (1) | YU81502A (et) |
| ZA (1) | ZA200208928B (et) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8110665B2 (en) | 2003-11-13 | 2012-02-07 | Hanmi Holdings Co., Ltd. | Pharmaceutical composition comprising an immunoglobulin FC region as a carrier |
| WO2005047334A1 (en) | 2003-11-13 | 2005-05-26 | Hanmi Pharmaceutical. Co., Ltd. | Igg fc fragment for a drug carrier and method for the preparation thereof |
| KR100754667B1 (ko) | 2005-04-08 | 2007-09-03 | 한미약품 주식회사 | 비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물 |
| EP1894601A1 (en) | 2006-08-29 | 2008-03-05 | sanofi-aventis | Treating mycobacterial infections with cyclipostins |
| KR200453850Y1 (ko) * | 2008-04-23 | 2011-05-30 | 주식회사 에이티티알앤디 | 수질 관리 센서 내장형 수도미터기 |
| KR102073748B1 (ko) | 2013-01-31 | 2020-02-05 | 한미약품 주식회사 | 재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법 |
| AR096891A1 (es) | 2013-07-12 | 2016-02-03 | Hanmi Pharm Ind Co Ltd | Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04145089A (ja) * | 1990-10-05 | 1992-05-19 | Nippon Kayaku Co Ltd | 抗生物質ｎｋ９０１０９３、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤 |
| JPH0656859A (ja) * | 1991-07-25 | 1994-03-01 | Nippon Kayaku Co Ltd | 抗生物質ｎｋ９０１０９３ａ、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤 |
-
2000
- 2000-05-04 DE DE10021731A patent/DE10021731B4/de not_active Expired - Fee Related
-
2001
- 2001-04-25 NZ NZ522352A patent/NZ522352A/en unknown
- 2001-04-25 SK SK1560-2002A patent/SK15602002A3/sk unknown
- 2001-04-25 WO PCT/EP2001/004652 patent/WO2001083497A1/de active IP Right Grant
- 2001-04-25 IL IL15261201A patent/IL152612A0/xx unknown
- 2001-04-25 DK DK01936275T patent/DK1280812T3/da active
- 2001-04-25 BR BR0110459-4A patent/BR0110459A/pt not_active IP Right Cessation
- 2001-04-25 HU HU0300306A patent/HUP0300306A3/hu unknown
- 2001-04-25 AU AU2001262229A patent/AU2001262229B2/en not_active Ceased
- 2001-04-25 KR KR1020027014691A patent/KR100779867B1/ko not_active IP Right Cessation
- 2001-04-25 PL PL01358328A patent/PL358328A1/xx unknown
- 2001-04-25 EE EEP200200599A patent/EE05090B1/et not_active IP Right Cessation
- 2001-04-25 ES ES01936275T patent/ES2236234T3/es not_active Expired - Lifetime
- 2001-04-25 EP EP01936275A patent/EP1280812B1/de not_active Expired - Lifetime
- 2001-04-25 DE DE50105249T patent/DE50105249D1/de not_active Expired - Lifetime
- 2001-04-25 CN CN018088813A patent/CN1216890C/zh not_active Expired - Fee Related
- 2001-04-25 JP JP2001580922A patent/JP5038572B2/ja not_active Expired - Fee Related
- 2001-04-25 AT AT01936275T patent/ATE288442T1/de active
- 2001-04-25 RU RU2002132558/04A patent/RU2266911C2/ru not_active IP Right Cessation
- 2001-04-25 CZ CZ20023547A patent/CZ20023547A3/cs unknown
- 2001-04-25 PT PT01936275T patent/PT1280812E/pt unknown
- 2001-04-25 YU YU81502A patent/YU81502A/sh unknown
- 2001-04-25 MX MXPA02010297A patent/MXPA02010297A/es active IP Right Grant
- 2001-04-25 AU AU6222901A patent/AU6222901A/xx active Pending
- 2001-04-25 CA CA2407808A patent/CA2407808C/en not_active Expired - Fee Related
- 2001-05-02 AR ARP010102068A patent/AR028398A1/es not_active Application Discontinuation
-
2002
- 2002-10-30 NO NO20025209A patent/NO330438B1/no not_active IP Right Cessation
- 2002-10-31 HR HRP20020864 patent/HRP20020864A2/xx not_active Application Discontinuation
- 2002-11-03 IL IL152612A patent/IL152612A/en not_active IP Right Cessation
- 2002-11-04 ZA ZA200208928A patent/ZA200208928B/en unknown
-
2003
- 2003-11-06 HK HK03108059A patent/HK1055745A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200100558A (et) | Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine | |
| BR0213242A (pt) | Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto | |
| NO20024772D0 (no) | Percyquinnin, fremgangsmåte for dets fremstilling og dets anvendelse som et legemiddel | |
| SE0103836D0 (sv) | Novel compounds | |
| EA200400432A1 (ru) | Производные мочевины | |
| ME00440B (me) | Novi $g(b kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto | |
| BR0316690A (pt) | Composto, prodroga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
| NO20062779L (no) | Vaksinesammensetning blandet med en alkylfosfatidylkolin | |
| EE200000472A (et) | Kasvajavastased toimeained | |
| SE9804212D0 (sv) | Compounds | |
| MXPA02012889A (es) | Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion. | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| UA93529C2 (ru) | Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами | |
| EE05090B1 (et) | Tsklipostiinihend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,hendi ja preparaadi valmistamine ning selleks vajalik mikroorganism | |
| MXPA04005484A (es) | Procedimiento de preparacion de derivados de equinocandina. | |
| SE0102057D0 (sv) | New Salts I | |
| WO2002100327A3 (en) | Substituted 1-benzazepines and derivatives thereof | |
| SE0202692D0 (sv) | Compounds | |
| DE69917668D1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
| EA200400409A1 (ru) | Новые соединения изохинолина, способ их получения и фармацевтические композиции, содержащие их | |
| SE0102058D0 (sv) | New Salts II | |
| AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
| GEP20032928B (en) | Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections | |
| HUP0303174A2 (hu) | A terbinafin almasav addíciós sói, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| DE60335960D1 (de) | 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20090425 |